Ensifentrine significantly improved lung function after 12 weeks in patients with moderate to severe COPD with and without ...

Although COVID-19 testing decreased during the study period, influenza and respiratory syncytial virus testing increased among hospitalized youth.

Patients treated for uncontrolled mild asthma had high symptom burden affecting their daily life but most had no ...

Cancer deaths have increased by more than 70% globally over the last 3 decades and are estimated to continue to climb, researchers report.

Race and economic disparities significantly affect lung cancer treatment and outcomes with worse outcomes seen in Black and ...

Most patients with persistent pulmonary symptoms after recovering from mild to moderate COVID-19 infection have normal ...

A significant percentage of patients with GCA present with atypical, nonclassical organ manifestations, including cardiac involvement and respiratory disease.

Vaping-related disorder is rare in patients with chronic lung disease but is also associated with a much higher likelihood of ...

Roughly 6 months after starting tezepelumab for severe asthma, many patients reduced OCS dependence and meaningfully improved ...

Asthma clinical remission among patients taking dupilumab is most likely to occur in those with increased baseline BEC and FeNO levels.

Adding paridiprubart to standard care in ICU patients with COVID respiratory distress may reduce invasive support needs and allow earlier discharge.

Prior COVID-19 infection was not independently associated with an increased risk for upper respiratory tract infections in adults.